Both in Pharmaceuticals
uniQure vs ANI Pharmaceuticals
Over the past year QURE returned −33.1% and ANIP returned −23.3%; their daily moves had a correlation of -0.03.
QURE −33.1% ANIP −23.3%Growth of $1, one year, split-adjusted
| Metric | QURE | ANIP |
|---|---|---|
| Price | $22.93 | $72.16 |
| Market cap | $1.59B | $1.66B |
| Today | −3.94% | −0.17% |
| 1 month | −0.6% | +0.9% |
| 6 months | +0.5% | −14.2% |
| Year to date | −4.2% | −8.6% |
| 1 year | −33.1% | −23.3% |
| Revenue growth (YoY) | +11.0% | +25.9% |
| Gross margin | 94.0% | 62.4% |
| Net margin | −1387.8% | 8.6% |
| P/E (TTM) | — | 16.6× |
| Price / sales | 85.2× | 1.7× |
| Net cash | $760.2M | -$234.7M |
| Dividend yield | — | — |
| Volatility (60d) | 109.2% | 26.7% |
| Short % of float | 13.2% | 18.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).